Your browser doesn't support javascript.
loading
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.
Iwakiri, Katsuhiko; Fujiwara, Yasuhiro; Manabe, Noriaki; Ihara, Eikichi; Kuribayashi, Shiko; Akiyama, Junichi; Kondo, Takashi; Yamashita, Hiroshi; Ishimura, Norihisa; Kitasako, Yuichi; Iijima, Katsunori; Koike, Tomoyuki; Omura, Nobuo; Nomura, Tsutomu; Kawamura, Osamu; Ohara, Shuichi; Ozawa, Soji; Kinoshita, Yoshikazu; Mochida, Satoshi; Enomoto, Nobuyuki; Shimosegawa, Tooru; Koike, Kazuhiko.
Afiliação
  • Iwakiri K; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan. k-iwa@nms.ac.jp.
  • Fujiwara Y; Department of Gastroenterology, Nippon Medical School Graduate School of Medicine, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. k-iwa@nms.ac.jp.
  • Manabe N; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Ihara E; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Kuribayashi S; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Akiyama J; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Kondo T; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Yamashita H; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Ishimura N; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Kitasako Y; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Iijima K; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Koike T; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Omura N; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Nomura T; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Kawamura O; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Ohara S; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Ozawa S; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Kinoshita Y; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Mochida S; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Enomoto N; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Shimosegawa T; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
  • Koike K; Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Gastroesophageal Reflux Disease", The Japanese Society of Gastroenterology, 6F Shimbashi i-MARK Building, 2-6-2 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan.
J Gastroenterol ; 57(4): 267-285, 2022 04.
Article em En | MEDLINE | ID: mdl-35226174
In Japan, with the increasing prevalence of gastroesophageal reflux disease (GERD) and growing public interest, the Japanese Society of Gastroenterology issued Evidence-based Clinical Practice Guidelines for GERD (1st edition) in 2009 and a revised 2nd edition in 2015. A number of studies on GERD were subsequently conducted in Japan and abroad, and vonoprazan, a potassium-competitive acid blocker (P-CAB), became available for the first time in Japan in February 2015. The revised 3rd edition (Japanese edition), which incorporates new findings and information, was published in April 2021. These guidelines are summarized herein, particularly sections related to the treatment of GERD. The important clinical issues addressed in the present revision are (i) the introduction of treatment algorithms that classify GERD into reflux esophagitis and non-erosive reflux disease, (ii) the clarification of treatment algorithms based on to the severity of reflux esophagitis, and (iii) the positioning of vonoprazan in the treatment for GERD. The present guidelines propose vonoprazan as the initial/maintenance treatment for severe reflux esophagitis. They also recommend vonoprazan or PPI as an initial treatment for mild reflux esophagitis and recommended PPI and proposed vonoprazan as maintenance treatment. These updated guidelines offer the best clinical strategies for GERD patients in Japan and hope that they will be of global use for the diagnosis and treatment for GERD.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esofagite Péptica / Refluxo Gastroesofágico / Gastroenterologia Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Idioma: En Revista: J Gastroenterol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esofagite Péptica / Refluxo Gastroesofágico / Gastroenterologia Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Idioma: En Revista: J Gastroenterol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão